They include the following: General fatigue, increased appetite, weight loss, heat intolerance, fever, excessive sweating; Central nervous system headache, hyperactivity, nervousness, anxiety, irritability, emotional lability, insomnia; Musculoskeletal tremors, muscle weakness; Cardiovascular palpitations, tachycardia, arrhythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction, cardiac arrest; withdrawal from synthroid symptoms dyspnea; Gastrointestinal diarrhea, vomiting, abdominal cramps and elevations in liver function tests; Dermatologic hair loss, flushing; Endocrine decreased bone mineral density; Reproductive menstrual irregularities, impaired fertility. Drug-Thyroidal Axis Interactions Drug or Drug Class Effect Drugs that may reduce TSH secretion – the reduction is not sustained; therefore, hypothyroidism does not occur Dopamine/Dopamine Agonists Glucocorticoids Octreotide Use of these agents may result in a transient reduction in TSH secretion when administered at the following doses: Dopamine (≥ 1 mcg/kg/min); Glucocorticoids (hydrocortisone ≥ 100 mg/day or equivalent); Octreotide (> 100 mcg/day). withdrawal from synthroid symptoms Synthroid only as prescribed by your physician. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Cardiovascular side effects have included symptoms of palpitations, hypertension, tachycardia, and angina which may be exacerbated in patients with underlying cardiovascular disorders.
synthroid false positive
If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist. It may take several weeks before your body starts to respond to this medication. Caution should be exercised when administering Synthroid to patients with underlying cardiovascular disease, to the elderly, and to those with concomitant adrenal insufficiency (see PRECAUTIONS ). Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. 6 Aluminum Lake, D&C Yellow No. Growth Hormones - withdrawal from synthroid symptoms - Somatropin Excessive use of thyroid hormones with growth hormones may accelerate epiphyseal closure. Package Label.Principal Display Panel NDC 0074-6624-19 1000 TABLETS SynthroidŽ (levothyroxine sodium withdrawal from synthroid symptoms USP) 100 mcg (0.1 mg) Rx only NSN 6505-01-042-9260 Do not accept if seal over bottle opening is broken or missing. Dermatologic Dermatologic side effects including transient dermatologic effect and hair loss have been reported during the initial months of therapy. Keep Synthroid in a tightly closed container. Different brands of levothyroxine may not work the same. 6 FD&C RED NO. Do not take extra medicine to make up the missed dose. 27 D&C RED NO. It may take several weeks before your body starts to respond to this medication. Thyroid hormones may increase the risk of coronary withdrawal from synthroid symptoms when sympathomimetic agents are administered to patients with coronary artery disease. The metabolic actions of thyroid hormones include augmentation of cellular respiration and thermogenesis, as well as metabolism of proteins, carbohydrates and lipids. Side Effects of Synthroid - for the Consumer Synthroid All medicines may cause side effects, but many people have no, or minor, side effects. What other drugs will affect levothyroxine? The following drugs may cause medical problems if you use them with levothyroxine: lithium, amiodarone, or antidepressants. 1 Product Characteristics Color BLUE (Turquoise) Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;137 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-3727-13 100 TABLET In 1 BOTTLE None 2 0074-3727-71 28 TABLET In 1 BOX None 3 0074-3727-19 1000 TABLET In 1 BOTTLE None Marketing Information Marketing Category Application Number or Monograph Citation Marketing withdrawal from synthroid symptoms Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product withdrawal from synthroid symptoms Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-7069 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 150 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C BLUE NO.
Pituitary TSH Suppression In the treatment or prevention of various types of euthyroid goiters (see WARNINGS and PRECAUTIONS), including thyroid withdrawal from synthroid symptoms (see WARNINGS and PRECAUTIONS ), subacute or chronic lymphocytic thyroiditis (Hashimoto's thyroiditis), multinodular goiter (see WARNINGS and PRECAUTIONS) and, as an adjunct to surgery withdrawal from synthroid symptoms radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. 1 Product Characteristics Color BROWN Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code Synthroid;125 Contains Packaging # NDC Package Description Multilevel Packaging 1 0074-7068-13 100 TABLET In 1 BOTTLE None 2 0074-7068-71 28 TABLET In 1 BOX None 3 0074-7068-19 1000 TABLET In 1 BOTTLE None withdrawal from synthroid symptoms 0074-7068-11 10 BLISTER PACK In 1 BOX, UNIT-DOSE withdrawal from synthroid symptoms withdrawal from synthroid symptoms BLISTER PACK 4 10 TABLET In 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0074-7068-11) Marketing Information Marketing Category Application Number or withdrawal from synthroid symptoms Citation Marketing Start Date Marketing End Date NDA NDA021402 07/24/2002 Synthroid levothyroxine sodium tablets tablet Product Information Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0074-3727 Route of Administration ORAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name withdrawal from synthroid symptoms of Strength Strength LEVOTHYROXINE SODIUM (LEVOTHYROXINE) LEVOTHYROXINE SODIUM 137 ug Inactive Ingredients Ingredient Name Strength ACACIA LACTOSE MONOHYDRATE MAGNESIUM STEARATE POVIDONE TALC FD&C BLUE NO. Proper storage of Synthroid: Store Synthroid between 68 and 77 degrees F (20 and 25 degrees C). Prothrombin time should be closely monitored to permit appropriate and timely dosage adjustments (see Table 2). Thyroid hormone products formulated for intravenous administration should be administered. Levothyroxine is in the FDA pregnancy category A. Amiodarone may induce hyperthyroidism by causing thyroiditis. Overtreatment may accelerate the bone age and result in premature epiphyseal closure and compromised adult stature. This means that it is safe to use while you are pregnant. Synthroid is a thyroid hormone. 10 Aluminum Lake, FD&C Yellow No. Specific indications include: primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) hypothyroidism and subclinical hypothyroidism.